Advances in dermatology最新文献

筛选
英文 中文
The "dysplastic" nevus: an update at 25 years. “发育不良”痣:25岁的更新。
Advances in dermatology Pub Date : 2003-01-01
R Wesley Wetherington, Clay J Cockerell
{"title":"The \"dysplastic\" nevus: an update at 25 years.","authors":"R Wesley Wetherington, Clay J Cockerell","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76978,"journal":{"name":"Advances in dermatology","volume":"19 ","pages":"237-48"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24084383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Merkel cell carcinoma. 默克尔细胞癌。
Advances in dermatology Pub Date : 2003-01-01 DOI: 10.1016/b978-0-323-39255-6.50255-6
Summer R Youker
{"title":"Merkel cell carcinoma.","authors":"Summer R Youker","doi":"10.1016/b978-0-323-39255-6.50255-6","DOIUrl":"https://doi.org/10.1016/b978-0-323-39255-6.50255-6","url":null,"abstract":"","PeriodicalId":76978,"journal":{"name":"Advances in dermatology","volume":"19 1","pages":"185-205"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"53965240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Merkel cell carcinoma. 默克尔细胞癌。
Advances in dermatology Pub Date : 2003-01-01
Summer R Youker
{"title":"Merkel cell carcinoma.","authors":"Summer R Youker","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Merkel cell carcinoma is an aggressive tumor that should be treated early and aggressively. Although there are 5 published cases of spontaneous regression of Merkel cell carcinoma, a patient's best chance for survival is early detection with either wide local excision or Mohs' micrographically controlled margins with a final 5- to 10-mm layer. This should be followed by sentinel lymph node biopsy with lymph node dissection of the draining basin if metastases are discovered. Adjuvant radiation to the primary site and the draining basin should follow. Although this aggressive approach to treatment is not appropriate for every case, the literature, although scanty, supports this. Chemotherapy with or without additional radiation therapy should be offered to patients with advanced disease, mostly for palliation. The need for prospective trials and longer follow-up for larger series of patients is obvious.</p>","PeriodicalId":76978,"journal":{"name":"Advances in dermatology","volume":"19 ","pages":"185-205"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24084381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BP180 (type XVII collagen) and its role in cutaneous biology and disease. BP180(XVII 型胶原蛋白)及其在皮肤生物学和疾病中的作用。
Advances in dermatology Pub Date : 2003-01-01
Françoise Van den Bergh, George J Giudice
{"title":"BP180 (type XVII collagen) and its role in cutaneous biology and disease.","authors":"Françoise Van den Bergh, George J Giudice","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>BP180 is a key component of the epidermal anchoring complex and functions to maintain adherence of the epidermis to the basement membrane. Structural studies have revealed that BP180 is a type II transmembrane protein with a long carboxy-terminal collagenous domain that projects into the extracellular region beneath the epidermal hemidesmosome. The collagenous domains have the characteristic tripeptide repeat, Gly-X-Y. A normal proteolytic processing event results in the shedding of the BP180 extracellular domain (LAD1) from the keratinocyte cell surface. The biologic relevance of this process is not yet known. The interactions of BP180 with other constituents of the anchoring complex have been extensively studied and underscore the importance of BP180 in the assembly and functioning of this cell-matrix adhesion structure. In addition to its role in maintaining the integrity of the dermal-epidermal junction, there is evidence that BP180 is involved in transmembrane signal transduction and in the regulation of keratinocyte differentiation. BP180 mutations are responsible for certain forms of JEB and a rare subform of epidermolysis bullosa simplex. In addition, 5 acquired blistering disorders (i.e. BP, HG, CP, LAD and LPP) are associated with an autoimmune response to BP180. In vivo and in vitro disease model systems have clearly established the pathogenic relevance of autoantibodies directed against specific sites on the BP180 extracellular domain. Molecular and cellular analyses of the autoimmune response in BP and HG have been unable to distinguish these 2 diseases, supporting the notion that HG can be considered a pregnancy-associated form of BP. In contrast, the anti-BP180 immune response of the other 3 disease--CP, LAD, and LPP--can be immunologically distinguished from BP and HG. The distinctions lie within the isotype and subclass of the autoantibodies, as well as in differences in their fine specificities or complement-fixing properties, or both. These differences are thought to account for the heterogeneous phenotypes observed in this family of autoimmune diseases.</p>","PeriodicalId":76978,"journal":{"name":"Advances in dermatology","volume":"19 ","pages":"37-71"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24084376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The cutaneous neurosensory system in skin disease. 皮肤病的皮肤神经感觉系统。
Advances in dermatology Pub Date : 2002-01-01
Franz J Legat, Cheryl A Armstrong, John C Ansel
{"title":"The cutaneous neurosensory system in skin disease.","authors":"Franz J Legat,&nbsp;Cheryl A Armstrong,&nbsp;John C Ansel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The cutaneous neurosensory system appears to be involved in a number of skin diseases. Ongoing studies continue to uncover potential new roles for the components of the neurosensory system in skin homeostasis and disease states. There is new evidence that neuropeptides may play a role in melanogenesis with effects on vitiligo. An increase of intraepidermal nerve fibers with a possible pathophysiologic role in photodamaged facial skin has been proposed. As our understanding of the interactions between the cutaneous neurosensory system and the various components of the skin and the immune system in times of health and disease increases, specific treatments modulating the neurocutaneous system will find their way into the armamentarium of daily dermatologic therapy.</p>","PeriodicalId":76978,"journal":{"name":"Advances in dermatology","volume":"18 ","pages":"91-109"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22196940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidermal nevi. 表皮痣。
Advances in dermatology Pub Date : 2002-01-01
Rudolf Happle, Maureen Rogers
{"title":"Epidermal nevi.","authors":"Rudolf Happle,&nbsp;Maureen Rogers","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76978,"journal":{"name":"Advances in dermatology","volume":"18 ","pages":"175-201"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22196816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in wound closure materials. 伤口闭合材料的研究进展。
Advances in dermatology Pub Date : 2002-01-01
Christie T Ammirati
{"title":"Advances in wound closure materials.","authors":"Christie T Ammirati","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76978,"journal":{"name":"Advances in dermatology","volume":"18 ","pages":"313-38"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22196820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Actinic keratoses: new treatment options. 光化性角化病:新的治疗选择。
Advances in dermatology Pub Date : 2002-01-01
Christine E Correale
{"title":"Actinic keratoses: new treatment options.","authors":"Christine E Correale","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76978,"journal":{"name":"Advances in dermatology","volume":"18 ","pages":"339-55"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22196821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphoma. 细胞因子和其他生物制剂作为皮肤t细胞淋巴瘤的免疫疗法。
Advances in dermatology Pub Date : 2002-01-01
Alain H Rook, Jacqueline M Junkins-Hopkins, Karen S McGinnis, Maria Wysocka, Stephen K Richardson, Jeanne B Budgin, Suzanne Everitts, Carmela C Vittorio
{"title":"Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphoma.","authors":"Alain H Rook,&nbsp;Jacqueline M Junkins-Hopkins,&nbsp;Karen S McGinnis,&nbsp;Maria Wysocka,&nbsp;Stephen K Richardson,&nbsp;Jeanne B Budgin,&nbsp;Suzanne Everitts,&nbsp;Carmela C Vittorio","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Cutaneous T-cell lymphomas (CTCLs) are a group of skin-invasive malignancies of clonally derived T lymphocytes. Mycosis fungoides and Sézary syndrome, characterized by the proliferation of CD4+ T cells, are the most common forms of CTCL. Among these latter disorders, the host antitumor response appears to play an important role in disease control. Thus, systemic therapeutic agents are used in an effort to augment the host antitumor response while selectively targeting the malignant cells. Both new and old biologic response-modifying treatment options currently used to treat CTCL are reviewed.</p>","PeriodicalId":76978,"journal":{"name":"Advances in dermatology","volume":"18 ","pages":"29-43"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22196938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of inflammatory dermatoses with novel biologic agents: a primer. 用新型生物制剂治疗炎症性皮肤病:引物。
Advances in dermatology Pub Date : 2002-01-01
Rachel Nussbaum, James G Krueger
{"title":"Treatment of inflammatory dermatoses with novel biologic agents: a primer.","authors":"Rachel Nussbaum,&nbsp;James G Krueger","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76978,"journal":{"name":"Advances in dermatology","volume":"18 ","pages":"45-89"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22196939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信